Where does IBC Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), IBC Pharmaceuticals, Inc. ranks #8,608 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does IBC Pharmaceuticals, Inc. hold?

IBC Pharmaceuticals, Inc. holds 37 US utility patents granted between 2015 and 2020, spanning 8 technology areas.

What is IBC Pharmaceuticals, Inc.'s Innovation Score?

IBC Pharmaceuticals, Inc. has an Innovation Score of 28.0 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does IBC Pharmaceuticals, Inc. focus on?

IBC Pharmaceuticals, Inc.'s top technology area is C07K (Peptides) with 37 patents, ranking #259 of 3,615 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is IBC Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

IBC Pharmaceuticals, Inc.'s recent grant velocity is -97% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for IBC Pharmaceuticals, Inc.'s patents?

IBC Pharmaceuticals, Inc.'s patents average 9.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the IBC Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

IBC Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 37 granted patents across 8 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, IBC ranks #8,608 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 8 technology areas.

#8,608
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.0/100): 9.1
avg claims per patent: -97%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8608 · US Corporation #8,608 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 37 grants
UPPER-Q #8,608/49,997
PHOTO-FINISH Hatch
CPC-NARROW C07K · 8 areas
INNOV-THIN 28.0/100
CLAIMS-PAR 9.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -97% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hatch Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How IBC’s 28.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.6 pts (45%) Velocity 0.0 pts (0%) Breadth 10.0 pts (36%) Claim depth 5.5 pts (20%)

Qualcomm Incorporated · highest

85
Bevilacqua Research · near

28
IBC Pharmaceuticals · this assignee

28
Marvell Hispania S L · near

28
Monk Akarshala… · near

28
PMC Industries · near

28
3D Lighting… · lowest

7

What this shows IBC's Innovation Score is 28.0/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for IBC?

Each dot is one of IBC’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). IBC’s own 9.1 claims/patent is at or below the 14.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

IBC vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where IBC's grants concentrate

IBC Pharmaceuticals, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2016 (11 grants) versus a trough of 1 in 2020. By volume, IBC sits between Hatch Ltd. and Inter-university Research Institute Coporation National Institutes OF Natural Sciences.

Hatch

37
House of Atlas

37
Humabs Biomed

37
Hutzler Manufactu…

37
Idex Biometrics A…

37
ILI Technology

37
Infinitum Electric

37
Inter-university…

37
IBC Pharmaceutica… ◀

37

What this shows IBC holds 37 patents at rank #8,608, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near IBC

By rank, the assignees closest to #8,608 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in IBC's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for IBC, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), IBC ranks #259 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (28 here).

PMC Industries, Inc. 28 Monk Akarshala Design Private Limited 28 Marvell Hispania, S.L. 28 Bevilacqua Research Corp 28

IBC's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

IBC Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	5.4%
2016	11	29.7%
2017	9	24.3%
2018	8	21.6%
2019	6	16.2%
2020	1	2.7%

Which technologies does IBC Pharmaceuticals, Inc. patent most?

C07K - Peptides 37

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 35

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 20

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 13

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 12

C12Y - Enzymes 11

Y02A - Technologies FOR Adaptation TO Climate Change 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

IBC Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

IBC Pharmaceuticals, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #8,608 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare IBC Pharmaceuticals, Inc. against Hatch Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.